The Epidemiology of Multidrug-Resistant Pathogens in Hematopoietic Stem Cell Transplantation (HSCT) Patients: A Five-Year Retrospective Study at a Cancer Center.

Sawsan Mubarak, Joud Jarrah, Yara K Edor, Omar Khresat, Hadeel AlGhawrie

Abstract read

In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sawsan MubarakInfection Control Program, King Hussein Cancer Center, Amman 11941, Jordan.

Joud JarrahDepartment of Medicine, King Hussein Cancer Center, Amman 11941, Jordan.

Yara K EdorDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.ORCID 0009-0007-7790-4488

Omar KhresatInfection Control Program, King Hussein Cancer Center, Amman 11941, Jordan.

Hadeel AlGhawrieInfection Control Program, King Hussein Cancer Center, Amman 11941, Jordan.ORCID 0000-0003-4390-4379

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant (MDR) pathogens present a significant threat to hematopoietic stem cell transplant (HSCT) recipients; despite their critical implications, regional data on their infection patterns remain scarce. This study aimed to characterize the incidence, pathogen and antimicrobial resistance distribution of clinically confirmed bacterial infections among HSCT recipients. A retrospective analysis was conducted at King Hussein Cancer Center, Jordan (2018-2022). MDR pathogens were defined per CDC criteria. During the study period, 1157 HSCT procedures were performed. A total of 327 patients developed clinically documented bacterial infections, yielding an overall cumulative incidence of 28.3%, with a higher burden in the pediatric cohort (34.7%), including exclusive identification of

Indexed as

BacteriaBacterial InfectionsDrug Resistance, Multiple, BacterialHematopoietic Stem Cell TransplantationAdolescentAdultAnti-Bacterial AgentsCancer Care FacilitiesChildChild, PreschoolFemaleHumansIncidenceInfantJordanMaleAnti-Bacterial Agentsantimicrobial resistanceepidemiologyextended-spectrum beta-lactamase (ESBL)Gram-negative bacteriahematopoietic stem cell transplantation (HSCT)multidrug-resistant pathogensretrospective study

Identifiers

PMID42515011

DOI10.3390/pathogens15070684

PMCPMC13414624

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.